Health-Related Quality-of-Life Analysis of Surufatinib Versus Placebo for Advanced Neuroendocrine Tumors: Pooled Results From Two Phase 3 Studies (SANET-p and SANET-ep)-MedSci.cn

Health-Related Quality-of-Life Analysis of Surufatinib Versus Placebo for Advanced Neuroendocrine Tumors: Pooled Results From Two Phase 3 Studies (SANET-p and SANET-ep)

Bai, CM; Xu, JM; Shen, L; Li, J; Zhou, ZW; Li, ZP; Chi, YHBL; Yu, XJ; Li, EX; Xu, N; Liu, TS; Lou, WH; Bai, YX; Yuan, XL; Wang, XW; Yuan, Y; Chen, J; Guan, S; Fan, SH; Su, WG

PANCREAS, 2022; 51 (3): E39

科室
- - 订阅+
  - 更多科室
工具
服务